BRIEF-Ariad completes rolling submission of NDA for Brigatinib to the U.S.

* Ariad completes rolling submission of new drug application for brigatinib to the u.s. Food and drug administration
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.